Evidence brief on facilitators, barriers and hesitancy of COVID-19 booster doses in Canada
Authors:
Open Access
- 3 October 2024
- journal article
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Canada Communicable Disease Report
- Vol. 50 (10) , 338-344
Abstract
Understanding the facilitators, barriers and hesitancy to accepting COVID-19 booster doses is important for encouraging recommended vaccination. This evidence brief summarizes literature on the intention to accept or reject COVID-19 vaccine booster doses and the factors associated with intention/uptake among individuals in Canada. A database of COVID-19 literature established at the Public Health Agency of Canada was searched for articles referencing vaccination and knowledge, attitudes and behaviours towards COVID-19 boosters. A grey literature search of Canadian governmental and academic institutions was also conducted. Primary research conducted in Canada (n=21) and relevant systematic reviews of the global literature (n=8) were included in this evidence brief. Intentions to get a booster dose in the general population have decreased between 2021–2023, with intentions varying across subpopulations. In Canada and within the global systematic reviews, facilitators, barriers and hesitancy were similar. Older age was the most common factor positively associated with intention/uptake of a booster, and the most common motivators were government/healthcare provider recommendations and helping to protect others. The main reasons for hesitancy were concerns about vaccine side effects and a lack of belief in the vaccine’s efficacy. Intentions to get a booster dose have decreased in Canada. Understanding the reasons for vaccine hesitancy and motivators for obtaining a booster can help guide future public health COVID-19 booster vaccination programs.Keywords
This publication has 19 references indexed in Scilit:
- Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic ReviewTropical Medicine and Infectious Disease, 2023
- Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE StudyVaccines, 2023
- COVID-19 literature surveillance—A framework to manage the literature and support evidence-based decision-making on a rapidly evolving public health topicCanada Communicable Disease Report, 2023
- A survey of COVID-19 vaccine acceptance across 23 countries in 2022Nature Medicine, 2023
- Combining Influenza and COVID-19 Booster Vaccination Strategy to Improve Vaccination Uptake Necessary for Managing the Health Pandemic: A Systematic Review and Meta-AnalysisVaccines, 2022
- COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-AnalysisTropical Medicine and Infectious Disease, 2022
- Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional surveyBMC Public Health, 2022
- A qualitative study exploring healthcare providers’ and trainees’ barriers to COVID-19 and influenza vaccine uptakeHealth Psychology and Behavioral Medicine, 2022
- First COVID-19 Booster Dose in the General Population: A Systematic Review and Meta-Analysis of Willingness and Its PredictorsVaccines, 2022
- Parents' perceptions on COVID-19 vaccination as the new routine for their children ≤ 11 years oldPreventive Medicine, 2022